en
Scientific article
English

Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling

Published inJournal of medicinal chemistry, vol. 45, no. 9, p. 1748-1756
Publication date2002
Abstract

A set of 29 3-alkyl 5-arylimidazolidinediones (hydantoins) with affinity for the human cannabinoid CB(1) receptor was studied for their lipophilicity and conformational properties in order to delineate a pharmacophore. These molecules constitute a new template for cannabinoid receptor recognition, since (a) their structure differs from that of classical cannabinoid ligands and (b) antagonism is the mechanism of action of at least three compounds (20, 21, and 23). Indeed, in the [(35)S]-GTP gamma S binding assay using rat cerebellum homogenates, they behave as antagonists without any inverse agonism component. Using a set of selected compounds, experimental lipophilicity was measured by RP-HPLC and calculated by a fragmental method (CLOGP) and a conformation-dependent method (CLIP based on the molecular lipophilicity potential). These approaches revealed two models which differentiate the binding mode of nonpolar and polar hydantoins and which could explain, at least for compounds 20, 21, and 23, the mechanism of action of this new family of cannabinoid ligands.

Keywords
  • Animals
  • Binding, Competitive
  • CHO Cells
  • Cannabinoids/*metabolism
  • Cerebellum/metabolism
  • Chromatography, High Pressure Liquid
  • Cricetinae
  • Crystallography, X-Ray
  • Humans
  • Hydantoins/*chemical synthesis/chemistry/metabolism
  • Ligands
  • Models, Molecular
  • Molecular Conformation
  • Radioligand Assay
  • Rats
  • Receptors, Cannabinoid
  • Receptors, Drug/antagonists & inhibitors/chemistry/*metabolism
  • Structure-Activity Relationship
Affiliation Not a UNIGE publication
Citation (ISO format)
OOMS, F. et al. Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling. In: Journal of medicinal chemistry, 2002, vol. 45, n° 9, p. 1748–1756. doi: 10.1021/jm010896y
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0022-2623
516views
0downloads

Technical informations

Creation08/06/2010 1:48:45 PM
First validation08/06/2010 1:48:45 PM
Update time03/14/2023 4:50:45 PM
Status update03/14/2023 4:50:44 PM
Last indexation02/12/2024 7:10:37 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack